Forte Biosciences Overview

  • Status
  • Private

  • Employees
  • 23

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 8

  • Investments
  • 1

Forte Biosciences General Information

Description

Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Corporate Office
  • 3060 Pegasus Park Drive
  • Building 6
  • Dallas, TX 75247
  • United States
+1 (310)
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • 3060 Pegasus Park Drive
  • Building 6
  • Dallas, TX 75247
  • United States
+1 (310)

Forte Biosciences Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Forte Biosciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Forte Biosciences‘s full profile, request access.

Request a free trial

Forte Biosciences Patents

Forte Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2020142780-A1 Car t cell methods and constructs Inactive 06-Jan-2019
WO-2020102437-A1 Recombinant vectors comprising genes for binding domains and secretable peptides Inactive 13-Nov-2018
WO-2019217203-A1 Compositions for the treatment of skin conditions Inactive 11-May-2018
WO-2019204475-A1 Compositions for the treatment of skin conditions Inactive 18-Apr-2018
WO-2017079695-A1 Gene expression patterns to predict responsiveness to virotherapy in cancer indications Inactive 05-Nov-2015 C12Q1/6886
To view Forte Biosciences’s complete patent history, request access »

Forte Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Forte Biosciences Acquisitions (1)

Forte Biosciences’s most recent deal was a Merger/Acquisition with Tocagen for . The deal was made on 15-Jun-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Tocagen 15-Jun-2020 Merger/Acquisition Drug Discovery
To view Forte Biosciences’s complete acquisitions history, request access »

Forte Biosciences FAQs

  • Where is Forte Biosciences headquartered?

    Forte Biosciences is headquartered in Dallas, TX.

  • What is the size of Forte Biosciences?

    Forte Biosciences has 23 total employees.

  • What industry is Forte Biosciences in?

    Forte Biosciences’s primary industry is Drug Discovery.

  • Is Forte Biosciences a private or public company?

    Forte Biosciences is a Private company.

  • What is the current valuation of Forte Biosciences?

    The current valuation of Forte Biosciences is .

  • What is Forte Biosciences’s current revenue?

    The current revenue for Forte Biosciences is .

  • How much funding has Forte Biosciences raised over time?

    Forte Biosciences has raised $328M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process